IMM 1.41% 35.0¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-26

  1. 299 Posts.
    lightbulb Created with Sketch. 101
    The deal making phase is Marc's domain and he comes with plenty of experience in this area. The ground work has been done in the patent/ due diligence department, as far as I can tell. Now we will see if the preparations for this phase deliver the outcomes we are daring to hope for.
    Considering the amount of data and trial related information which has been know in-house for some time. The planned company shareholder update may provide business deal/ development clarity. Time will tell.
    I feel like a couple of those shots on goal may have hit the Marc and Us retail folks are outside the stadium watching a delayed broadcast of the big game on a small screen. Best we can hope for I think. Pick up a few more shares today. Don't tell anyone. GLTA.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.005(1.41%)
Mkt cap ! $508.4M
Open High Low Value Volume
35.5¢ 37.0¢ 35.0¢ $906.4K 2.522M

Buyers (Bids)

No. Vol. Price($)
5 71513 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 113290 6
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.